6:54 PM · 28 February 2024

UnitedHealth drops 5% on antitrust investigation

UnitedHealth
Stocks
UNH.US, UnitedHealth Group Inc
-
-

UnitedHealth Group (UNH.US) is the worst performing S&P 500 stock today and drops around 5% on the day. The drop comes after Bloomberg reported that US Department of Justice launched an antitrust investigation into the company.

Bloomberg report is based on the information provided by an anonymous informant suggests that regulatory concerns primarily focus on the conversion of the insurance branch's customers into customers of the Optum executive arm. The most well-known insurance unit of the company, UnitedHealthcare, covering over 47 million Americans, is gaining a growing share of revenues and profits from companies providing healthcare services under its Optum executive arm. Optum clinics offering home care services, creating drug plans, and delivering medications often provide services to UnitedHealthcare members, allowing the company to transform insurance-related expenses into revenue for Optum. This arrangement has historically helped drive the growth of UnitedHealth.

Taking a look at UnitedHealth chart (UNH.US) at D1 interval, we can see that the stock is plunging below 200-session moving average (purple line) and $505 support zone today. Stock is trading at the lowest level since January 24, 2024. The near-term support zone to watch should declines continue can be found in the $475 area.

Source: xStation5

7 October 2025, 10:25 AM

DE40: Europan market still under pressure of weak industry and political turmoil

6 October 2025, 7:14 PM

Daily summary: US100 surges almost 1% 📈Crypto and precious metals on the rise

6 October 2025, 3:06 PM

Stock of the Month: Will Meta win the AI ​​race?

6 October 2025, 1:03 PM

AMD rises on the wave of the OpenAI deal. Pre-market trading shows a 25% increase in shares.

Join over 1 700 000 XTB Group Clients from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits